Legal Representation
Attorney
Tara Reedy Sliva
USPTO Deadlines
Next Deadline
1589 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2023-12-05)
Due Date
December 05, 2029
Grace Period Ends
June 05, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
9 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Dec 5, 2023 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Dec 5, 2023 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Sep 19, 2023 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Sep 19, 2023 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Aug 30, 2023 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Aug 11, 2023 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Aug 9, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jul 13, 2023 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 13, 2023 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Medicinal preparations, namely, photosensitizing agents used as a dermatologic drug for the treatment of skin cancer by phototherapy; Chemical reagents for medical or veterinarian use; Chemical reagents for use as culture media for cultures of microorganisms for medical use, namely, for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Organic chemical preparations for medical purposes, namely, immunomodulators with anti-inflammatory properties; Organic chemical preparations and enzymes for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA)
First Use Anywhere:
Apr 28, 2010
First Use in Commerce:
Apr 28, 2010
Classification
International Classes
005